Sickle Cell Disease: Improving the Quality and Continuum of Acute and Ambulatory Patient Care
Released On
December 22, 2022
Expires On
December 22, 2023
Media Type
Internet
Completion Time
90 minutes
Specialty
Critical Care, Hematology, Pain Management, Pediatrics
Topic(s)
Blood Disorders, Medication Therapy Management, New Drugs, Pain Management, Pediatrics
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Agios Pharmaceuticals, Inc and Chiesi USA.
Credit Available
- Physicians — maximum of 1.5 AMA PRA Category 1 Credits™
- Nurses — 1.5 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is directed toward hematologists, cardiologists, pulmonologists, neurologists, primary care physicians, and advanced clinical practitioners who work with sickle cell disease (SCD) patients.
Activity Overview
In this video-based activity, a panel of 4 distinguished experts in managing SCD review clinical guidelines, interpret clinical latest data regarding current and emerging therapeutic strategies, and engage in lively discussion about best practices related to the care of patients with SCD.
Learning Objectives
- Implement individualized, evidence-based strategies for managing acute and chronic pain in pediatric patients with sickle cell disease.
- Evaluate the efficacy and safety of approved and emerging therapies for the management of patients with sickle cell disease.
- Describe the impact of health-related stigma on treatment practices and health outcomes in sickle cell disease.
- Outline important components of a successful transition process from pediatric to adult care in sickle cell disease.
- Develop treatment plans from best practices to support patients with psychosocial health needs.
Faculty
Nirmish Shah, MD
Associate Professor
Director of Sickle Cell Transition Program
Division of Hematology and Pediatric Hematology/Oncology
Duke University
Durham, NC
Matthew Heeney, MD
Orah S Platt Chair in Hematology
Associate Chief - Hematology
Director - Sickle Cell Program
Boston Children's Hospital
Associate Professor of Pediatrics
Harvard Medical School
Boston, MA
Charles R. Jonassaint, PhD, MHS
Associate Professor
Department of Medicine
University of Pittsburgh
Pittsburgh, PA
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
- Nirmish Shah, MD
- Grant/Research Support: GBT
- Consultant: Agios, bluebird bio, Emmaus, Forma, GBT, Novartis
- Speaker's Bureau: Alexion, Emmaus, GBT
- Matthew Heeney, MD
- Consultant: bluebird bio, FORMA, Global Blood Therapeutics, Novartis, Oric, Pharmacosmos, Vertex/CRISPR
Charles R. Jonassaint, PhD, MHS, has no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.